Intelligence Platform
Patents
Browse 738 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9757424
Compositions and methods of treating gliomas
granted patentUS 9745572
Method for identifying antibiotic targets
granted patentUS 9732095
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
granted patentUS 9731037
Scanning suspension comprising a particle with a diameter of at least 1 micrometer
granted patentUS 9714244
Substituted pyrido[4,3-d]pyrimidines as Wee-1 inhibitors
granted patentUS 9707215
Inhibitors of hepatitis C virus polymerase
granted patentUS 9682969
Phthalazinone compounds and methods for the treatment of cystic fibrosis
granted patentUS 9677143
Compositions and methods for the identification of inhibitors of retroviral infection
granted patentUS 9676779
Small molecule CFTR correctors
granted patentUS 9670177
Crystalline C21H22Cl2N4O2 malonate
granted patentUS 9657270
Human disc tissue
granted patentUS 9642898
Use of serine protease inhibitors in the treatment of neutropenia
granted patentUS 9636649
Dispersions comprising discrete carbon nanotube fibers
granted patentUS 9630932
Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors
granted patentUS 9623055
Method for preventing and/or treating insulin resistance
granted patentUS 9597353
Redox signaling gel formulation
granted patentUS 9598414
Substituted benzo[5,6]azepino[3,2,1-hi]pyrido[4,3-b]indoles and substituted benzo[6,7][1,4
granted patentUS 9580438
Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoi
granted patentUS 9573948
Triazolopyridine compounds and methods for the treatment of cystic fibrosis
granted patentUS 9567345
Pharmaceutically active pyrazolo-triazine derivatives
granted patentUS 9546176
Small molecule bicyclic and tricyclic CFTR correctors
granted patentUS 9522112
System, method, and kit for selecting and preparing customized cosmetics
granted patentUS 9517222
Method for the treatment of senile dementia of the Alzheimer's type
granted patentUS 9517228
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders,
granted